5-HT (10 and 40 micrograms) and
8-OH-DPAT (1 and 5 micrograms) were locally applied into the dorsal or median raphe nuclei in awake, unrestrained, rats. All animals were also treated with the
5-HTP and
DOPA decarboxylase inhibitor
NSD-1015, 100 mg kg-1 SC, 30 min before
decapitation.
5-HT or
8-OH-DPAT were administered 5 min before
NSD-1015. The regional brain in vivo rate of
tyrosine and
tryptophan hydroxylase activity was estimated by measuring the accumulation of
DOPA and
5-HTP. The following brain regions were sampled: neocortex, hippocampus, dorso-lateral neostriatum, ventro-medial neostriatum, nucleus accumbens, olfactory tubercle, globus pallidus, septum and the amygdala. Compared to normal controls, there were small and inconsistent effects on forebrain
5-HTP accumulation by saline
injections into the dorsal or the median raphe (an increase in 3 out of 36 experiments), whereas strong effects by the injection procedure were noted on forebrain
DOPA accumulation (an increase in 15 out of 36 experiments).
Injections of
5-HT (same effect by 10 or 40 micrograms) into the dorsal raphe, produced a decrease in
5-HTP accumulation in all forebrain areas except for the hippocampus and the septum, whereas no effects were seen in any area after median raphe
injections. In contrast,
8-OH-DPAT preferentially produced a decrease in forebrain
5-HTP accumulation after median raphe
injections and less, but statistically significant effects by dorsal raphe
injections. The
8-OH-DPAT injection into the median raphe primarily affected limbic forebrain areas (hippocampus, nucleus accumbens, ventro-medial neostriatum, amygdala and the septum). This dissociation of the effects of
5-HT and
8-OH-DPAT on forebrain
5-HT synthesis after local application into the dorsal or the median raphe strongly supports the contention of heterogeniety in the brain
5-HT receptor population in terms of receptor subtypes and/or receptor regulation.